l

The content of this website is intended for healthcare professionals only

Maternal gestational diabetes increases risk of autism

Study finds link with intrauterine exposure

Jo Carlowe

Wednesday, 15 April 2015

Intrauterine exposure to gestational diabetes mellitus is associated with a risk of autism spectrum disorders (ASDs), according to new findings. 

The study*, published in JAMA, comprised data taken from more than 320,000 children. Anny H. Xiang, of Kaiser Permanente Southern California, and colleagues, analysed data from a single health care system to assess the association between maternal diabetes, both known prior to pregnancy and diagnosed during pregnancy, and the risk of ASD in children. The study included 322,323 children born from 1995-2009 at Kaiser Permanente Southern California (KPSC) hospitals. Children were tracked from birth until the first of the following: date of clinical diagnosis of ASD, last date of continuous KPSC health plan membership, death due to any cause, or 31 December 2012.

Of the children included in the study, 6,496 (2%) were exposed to pre-existing type 2 diabetes, 25,035 (7.8%) were exposed to GDM, and 290,792 (90.2%) were unexposed. Following birth (median of 5.5 years), 3,388 children were diagnosed as having ASD (115 exposed to pre-existing type 2 diabetes, 130 exposed to GDM at 26 weeks or less, 180 exposed to GDM at more than 26 weeks, and 2,963 unexposed). After adjustment for various factors, including maternal age, household income, race/ethnicity, and sex of the child, GDM diagnosed by 26 weeks was significantly associated with risk of ASD in offspring, but maternal pre-existing type 2 diabetes was not. Antidiabetic medication use was not independently associated with ASD risk in offspring.

Exposure of foetuses to maternal hyperglycaemia may have long-lasting effects on organ development and function. Previous studies have revealed long-term risks of obesity and related metabolic disorders in offspring of women who had diabetes prior to pregnancy as well as women with hyperglycaemia first detected during pregnancy. Whether such exposure can disrupt foetal brain development and heighten risk of neurobehavioral developmental disorders in offspring is less clear, according to background information in the article.

The authors write that potential biological mechanisms linking intrauterine hyperglycaemia and ASD risk in offspring may include multiple pathways, such as hypoxia in the foetus, oxidative stress in cord blood and placental tissue, chronic inflammation, and epigenetics.


* Anny H. Xiang, et al. Association of Maternal Diabetes With Autism in Offspring. JAMA. 2015;313(14):1425-1434. doi:10.1001/jama.2015.2707.

Registered in England and Wales. Reg No. 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Reg No. 30158470